Bianchi, Antonio
 Distribuzione geografica
Continente #
EU - Europa 2.412
NA - Nord America 2.294
AS - Asia 350
AF - Africa 12
SA - Sud America 12
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 1
Totale 5.087
Nazione #
US - Stati Uniti d'America 2.284
DE - Germania 895
SE - Svezia 403
IT - Italia 272
CN - Cina 244
UA - Ucraina 214
PL - Polonia 208
IE - Irlanda 132
FR - Francia 97
GB - Regno Unito 63
FI - Finlandia 59
IN - India 38
BE - Belgio 24
IR - Iran 16
TR - Turchia 13
JP - Giappone 12
NL - Olanda 12
VN - Vietnam 11
CA - Canada 10
CI - Costa d'Avorio 9
SG - Singapore 9
CH - Svizzera 7
RU - Federazione Russa 6
CO - Colombia 5
BR - Brasile 4
ES - Italia 4
HK - Hong Kong 4
A2 - ???statistics.table.value.countryCode.A2??? 3
EU - Europa 3
LT - Lituania 2
PE - Perù 2
RO - Romania 2
AL - Albania 1
AT - Austria 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
CL - Cile 1
CZ - Repubblica Ceca 1
EG - Egitto 1
GR - Grecia 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
IQ - Iraq 1
KR - Corea 1
LI - Liechtenstein 1
MA - Marocco 1
MD - Moldavia 1
NO - Norvegia 1
PT - Portogallo 1
SC - Seychelles 1
Totale 5.087
Città #
Chandler 559
Warsaw 195
Ashburn 154
Dublin 121
San Mateo 111
Ann Arbor 107
New York 100
Fairfield 93
Jacksonville 86
Wilmington 82
Nanjing 58
Boston 56
Marseille 54
Seattle 49
Woodbridge 48
Nürnberg 45
Princeton 45
Bremen 43
Houston 42
Rome 42
Cattolica 34
Milan 34
Dearborn 33
Zhengzhou 29
Redwood City 27
Cambridge 25
Nanchang 24
Brussels 23
Helsinki 23
Lawrence 23
Mountain View 23
Beijing 21
University Park 19
Munich 16
Boardman 15
Shenyang 15
Kraków 13
Norwalk 13
Leawood 12
Kunming 11
Los Angeles 11
Shanghai 11
Augusta 10
Fremont 10
Hangzhou 10
Hebei 10
Izmir 10
Kish 10
Abidjan 9
Chicago 9
Tianjin 9
Changsha 8
Redmond 8
Brescia 7
Guangzhou 7
Hanoi 7
Jiaxing 7
Piacenza 7
Simi Valley 7
Washington 7
Detroit 6
Jinan 6
Pune 6
Singapore 6
Ferrara 5
Lancaster 5
Menlo Park 5
Mumbai 5
Renton 5
Dong Ket 4
Hong Kong 4
London 4
Ningbo 4
Sakaemachi 4
West Jordan 4
Amsterdam 3
Andover 3
Bari 3
Bergamo 3
Busto Arsizio 3
Cedar Crest 3
Edinburgh 3
Fuzhou 3
Gunzenhausen 3
Indiana 3
Meda 3
Mercato San Severino 3
Ottawa 3
Philadelphia 3
Phoenix 3
Sacramento 3
São Paulo 3
Ardabil 2
Bern 2
Bogen 2
Bogotá 2
Buffalo Junction 2
Clearwater 2
Cornaredo 2
Cumiana 2
Totale 2.837
Nome #
Increased FGF23 serum level is associated with unstable carotid plaque in type 2 diabetic subjects with internal carotid stenosis. 336
Hypophysitis Outcome and Factors Predicting Responsiveness to Glucocorticoid Therapy: A Prospective and Double-Arm Study. 228
Radically resected pituitary adenomas: prognostic role of Ki 67 labeling index in a monocentric retrospective series and literature review 224
Double pituitary adenomas 185
Predictors of morbidity and mortality in acromegaly, an Italian survey. 184
Coenzyme Q10 evaluation in pituitary-adrenal axis disease: preliminary data. 140
Non Alcoholic Fatty Liver Disease is Associated with Increased GHBP and Reduced GH/IGF-I Levels 133
Typical and Atypical Pituitary Adenomas: A Single-Center Analysis of Outcome and Prognosis 133
Effects of gherlin administration on endocrine and metabolic parameters in obese women with polycystic ovary syndrome 127
Asthma in patients admitted to emergency department for COVID-19: prevalence and risk of hospitalization 123
Increased estradiol levels in venous occlusive disorder: a possible functional mechanism of venous leakage. 121
An Overview of Diagnosis of Primary Autoimmune Hypophysitis in a Single Prospective Monocentric Experience 119
Hypothalamitis: a diagnostic and therapeutic challenge 104
Ki-67 grading of nonfunctioning pancreatic neuroendocrine tumors on histologic samples obtained by EUS-guided fine-needle tissue acquisition: a prospective study 103
Influence of diabetes mellitus on vertebral fractures in men with acromegaly 99
Effects of ghrelin administration on endocrine and metabolic parameters in obese women with polycystic ovary syndrome 94
The effect of treatment with growth hormone on fertility outcome in eugonadal women with growth hormone deficiency: report of four cases and review of the literature 91
Long-term treatment of somatostatin analog-refractory growth hormone-secreting pituitary tumors with pegvisomant alone or combined with long-acting somatostatin analogs: a retrospective analysis of clinical practice and outcomes 89
Glucocorticoid replacement therapy and vertebral fractures in hypopituitary adult males with GH deficiency 88
Significant GH-deficiency after long-term cure by surgery in adult patients with Cushing s disease 86
Hypopituitarism findings in patients with primary brain tumors 1 year after neurosurgical treatment: preliminary report. 80
GH receptor isoforms and skeletal fragility in acromegaly 80
Hormonal and metabolic evaluation in Down's syndrome: preliminary evidence for TSH dysregulation in hyperthyrotropinemic patients 77
DIAGNOSIS OF ENDOCRINE DISEASE: Primary Empty Sella: a comprehensive review 72
Pegvisomant and Pasireotide LAR as second line therapy in acromegaly: clinical effectiveness and predictors of response 68
High prevalence of radiological vertebral fractures in women with prolactin-secreting pituitary adenomas 66
Nonthyroidal illness syndrome and prolonged mechanical ventilation in patients admitted to the ICU. 63
Risk factors for pancreas and lung neuroendocrine neoplasms: a case–control study 62
The exon 3-deleted growth hormone receptor: Molecular and functional characterization and impact on GH/IGF-I axis in physiological and pathological conditions 61
Synchronous Bilateral Adrenalectomy in ACTH-dependent Hypercortisolism: Predictors, Biomarkers and Outcomes 61
Vertebral fractures in patients with acromegaly: a 3-year prospective study 60
Effect of gonadal status on bone mineral density and radiological spinal deformities in adult patients with growth hormone deficiency 59
Factors predicting pasireotide responsiveness in somatotroph pituitary adenomas resistant to first-generation somatostatin analogues: an immunohistochemical study. 59
Spontaneous thyroid nodule hemorrhage in the emergency department 59
Clinical management of teratoma, a rare hypothalamic-pituitary neoplasia 57
Long-term effects of the combination of pegvisomant with somatostatin analogs (SSA) on glucose homeostasis in non-diabetic patients with active acromegaly partially resistant to SSA 53
Human leucocyte antigens coeliac haplotypes and primary autoimmune hypophysitis in caucasian patients 53
Neuro-radiological features can predict hypopituitarism in primary autoimmune hypophysitis 52
Effects of thyroid hormone treatment on diaphragmatic efficiency in mechanically ventilated subjects with nonthyroidal illness syndrome 51
Vertebral fractures in males with prolactinoma. 50
Increased prevalence of radiological spinal deformities in adult patients with GH deficiency: influence of GH replacement therapy. 50
Reappraising the Role of Trans-Sphenoidal Surgery in Prolactin-Secreting Pituitary Tumors. 49
The changing clinical spectrum of endocrine adverse events in cancer immunotherapy 48
The Role of Growth Hormone Receptor Isoforms and Their Effects in Bone Metabolism and Skeletal Fragility 46
Empty sella syndrome: Multiple endocrine disorders. 45
Growth hormone receptor isoforms and fracture risk in adult-onset growth hormone-deficient patients. 45
Short- and long-term responsiveness to low dose growth hormone (GH) in adult GH deficiency: Role of GH receptor polymorphism. 44
Understanding the effect of acromegaly on the human skeleton. 44
Tumour-infiltrating cytotoxic T lymphocytes in somatotroph pituitary neuroendocrine tumours 44
Proteomics of Pancreatic Neuroendocrine Tumors: A Systematic Review 43
Galectin-3 and Estrogen Receptor Alpha as Prognostic Markers in Prolactinoma: Preliminary Results From a Pilot Study 43
Protein Expression of PTTG-1, OCT-4, and KLF-4 in Seminoma: A Pilot Study. 42
Multidimensional geriatric evaluation in acromegaly: a comparative cross-sectional study 42
Pasireotide, a multiple somatostatin receptor subtypes ligand, reduces cell viability in non-functioning pituitary adenomas by inhibiting vascular endothelial growth factor secretion. 41
Microalbuminuria in insulin sensitivity in patients with growth hormone-secreting pituitary tumor. 41
First Case of Mature Teratoma and Yolk Sac Testis Tumor Associated to Inherited MEN-1 Syndrome. 40
Glucose metabolism outcomes in acromegaly patients on treatment with pasireotide-LAR or pasireotide-LAR plus Pegvisomant 40
Autoantibody reactivity profile of primary autoimmune hypophysitis patients: preliminary results 40
Hypothalamitis and pituitary atrophy 38
Prevalence of morphometric vertebral fractures in "difficult" patients with acromegaly with different biochemical outcomes after multimodal treatment. 37
Effects of pegvisomant and somatostatin receptor ligands on incidence of vertebral fractures in patients with acromegaly. 36
Nonthyroidal illness syndrome and prolonged mechanical ventilation in patients admitted to the ICU 35
Acromegaly can be cured by first-line pasireotide treatment? 35
Effects of Pegvisomant and Pasireotide LAR on Vertebral Fractures in Acromegaly Resistant to First-generation SRLs. 35
Increased prevalence of radiological spinal deformities in active acromegaly: a cross-sectional study in postmenopausal women. 34
Acromegaly in the elderly patients 32
Treatment of Acromegalic Osteopathy in Real-life Clinical Practice: The BAAC (Bone Active Drugs in Acromegaly) Study 28
Competitive testing of the WHO 2010 versus the WHO 2017 grading of pancreatic neuroendocrine neoplasms: Data from a large international cohort study 26
Pituitary Enlargement and Hypopituitarism in Patients Treated with Immune Checkpoint Inhibitors: Two Sides of the Same Coin? 24
Systemic comorbidities of acromegaly in real-life experience: which difference among young and elderly patients? 13
Safety and efficacy of endoscopic ultrasound-guided radiofrequency ablation for pancreatic insulinoma: A single-center experience 12
Pediatric craniopharyngiomas: magnetic resonance imaging assessment for hypothalamus-pituitary axis dysfunction and outcome prediction 6
The Pathogenic RET Val804Met Variant in Acromegaly: A New Clinical Phenotype? 6
Multidisciplinary management of difficult/aggressive growth-hormone pituitary neuro-endocrine tumors 3
Markers of humoral and cell-mediated immune response in primary autoimmune hypophysitis: a pilot study 3
Cholecalciferol Use Is Associated With a Decreased Risk of Incident Morphometric Vertebral Fractures in Acromegaly 3
Second line treatment of acromegaly: Pasireotide or Pegvisomant? 2
Two diagnostic pitfalls mimicking a prolactin-secreting microadenoma 2
Unveiling the Etiopathogenic Spectrum of Hypophysitis: A Narrative Review 2
Pancreas as an Unusual Metastatic Site of Medullary Thyroid Carcinoma: A Case of Very Long-term Follow-up Under Prolonged Treatment with Somatostatin Analogues 1
CD68+ and CD8+ immune cells are associated with the growth pattern of somatotroph tumors and response to first generation somatostatin analogs 1
Trouillas’s Grading and Post-Surgical Tumor Residue Assessment in Pituitary Adenomas: The Importance of the Multidisciplinary Approach 1
The multi-biomarker acro-TIME score predicts fg-SRLs response: preliminary results of a retrospective acromegaly cohort 1
Impact of the diagnostic delay of acromegaly on bone health: data from a real life and long term follow-up experience 1
Trouillas's Grading and Post-Surgical Tumor Residue Assessment in Pituitary Adenomas: The Importance of the Multidisciplinary Approach 1
De-escalation treatment with pasireotide for acromegaly: a long-term experience 1
Aggressive PitNETs and Potential Target Therapies: A Systematic Review of Molecular and Genetic Pathways 1
Partial response to first generation SSA guides the choice and predict the outcome of second line therapy in acromegaly 1
Use of 111In-pentetreotide scintigraphy for diagnosis and management of resistant macroprolactinoma 1
Letter: A Multicenter, Propensity Score- Matched Assessment of Endoscopic Versus Microscopic Approaches in the Management of Pituitary Adenomas 1
Totale 5.260
Categoria #
all - tutte 18.603
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.603


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019134 0 0 0 0 0 0 0 0 0 38 39 57
2019/2020806 109 35 59 99 57 60 143 50 44 35 68 47
2020/2021486 28 53 14 49 57 30 55 12 50 44 83 11
2021/2022680 26 40 9 51 85 32 18 114 24 41 97 143
2022/20231.500 169 204 130 247 88 178 88 127 163 12 57 37
2023/2024553 32 173 27 36 36 129 40 19 30 31 0 0
Totale 5.260